Characterization and validation of potential therapeutic targets based on the molecular signature of patient-derived xenografts in gastric cancer
Zuhua Chen(Peking University Cancer Hospital), Lin Shen(Peking University)
Cited by 44
Related Papers
Augmented antitumor activity by olaparib plus AZD1775 in gastric cancer through disrupting DNA damage repair pathways and DNA damage checkpoint
|Journal of Experimental & Clinical Cancer Research|2018|56
CLDN18.2 and 4-1BB bispecific antibody givastomig exerts antitumor activity through CLDN18.2-expressing tumor-directed T-cell activation
|Journal for ImmunoTherapy of Cancer|2023|39
Pyrotinib combined with CDK4/6 inhibitor in HER2‐positive metastatic gastric cancer: A promising strategy from AVATAR mouse to patients
|Clinical and Translational Medicine|2020|31
From AVATAR Mice to Patients: RC48-ADC Exerted Promising Efficacy in Advanced Gastric Cancer With HER2 Expression
|Frontiers in Pharmacology|2022|25